Capsule of thyroid nodule
|
|
- Archibald Cameron
- 7 years ago
- Views:
Transcription
1 of thyroid nodule of Follicular Cell Tumors, its Significance and Morphology RYOHEI KATOH, TADAO NAKAZAWA, AND TETSUO KONDO DEPARTMENT OF HUMAN PATHOLOGY UNIVERSITY OF YAMANASHI, JAPAN NODULAR GOITER FOLLICULAR ADENOMA FOLLICULAR CARCINOMA PAPILLARY CARCINOMA POORLY DIFFERENTIATED CARCINOMA MEDULLARY CARCINOMA OTHERS CAPSULE OF THYROID NODULE CAPSULE IN PAPILLARY THYROID CARCINOMA Nodular goiter NON-ENCAPSULATED TYPE ENCAPSULATED TYPE CYSTIC TYPE Follicular adenoma/carcinoma MACROSCOPIC TYPES OF PAPILLARY THYROID CARCINOMAS DIAGNOSIS OF FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA Encapsulated type 6% CLASSICAL TYPE Partly encapsulated type Non-encapsulated type Cystic type 11% 75% 7% (150 PTCs with classical histology) PAPILLARY THYROID CARCINOMA Liu J, et al. Cancer 2006;107: FOLLICULAR VARIANT NON-ENCAPSULATED TYPE ENCAPSULATED TYPE PROBLEMATIC ISSUE
2 ENCAPSULATE FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA s with a small number of PTC nuclei and/or questinable PTC nuclei often diagnosed High as observer Encapsulated variation follicular variant of PTC WITH EFV-PTC FTC MALIGNANT WITHOUT WDT-IMP WELL-DIFFERENTIATED TUMOUR OF INDETERMINATED MALIGNANT POTENTIAL Williams ED Int J Surg Pathol 2000, 8: This tumor should be treated as BENIGN. FOLLICULAR ADENOMA/CARCINOMA FOLLICULAR ADENOMA/CARCINOMA ADENOMA CARCINOMA A BENIGN ENCAPSULATED TUMOUR OF THE THYROID SHOWING EVIDENCE OF FOLLICULAR CELL DIFFERENTIATION A MALIGNANT EPITHELIAL TUMOUR SHOWING EVIDENCE OF FOLLICULAR CELL DIFFERENTIATION AND LACKING THE DIAGNOSTIC NUCLEAR FEATURE OF PAPILLARY CARCINOMA. Diagnostic algorithm of follicle forming thyroid nodule PERHAPS THE MOST DIFFICULT PROBLEM IN THYROID PATHOLOGY IS THE DISTINCTION OF FOLLICULAR CARCINOMA FROM FOLLICULAR ADENOMA AND FROM THE FOLLICULAR VARIANT OF PAPILLARY CARCINOMA. Evans HL. Cancer 54: , 1984 thyroid nodule Poorly diff. carcinoma Follicular carcinoma Papillary carcinoma cell nuclei + Papillary carcinoma Hyalinizing trabecular tumour Nodular goiter Follicular a./c. Poorly diff. carcinoma Solid, trabecular, insular pattern, necrosis, mitosis Follicular c. Poorly diff. c. Invasion + - Follicular a. Nodular goiter
3 I My PROCEDURE S Cover glass 24mm Capsular invasion Vascular invasion Longitudinal sections Nodule <= 2cm Most of sections should include the tumour capsule and adjacent throid tissue, if present Entire nodule Nodule > 2cm 10 sections + Additional sections nodulectomy, lobectomy, subtotal/total thyroidectomy Patterns of Capsular Invasion (CI) 1. CAPSULAR (CI) True CI Insufficient CI True CI True CI Insufficient CI Capsular invasion is defined by tumour penetration through the tumour capsule unassociaqted with the site of a previous fine needle aspiration biopsy. (WHO 2004) Patterns of Capsular Invasion (CI) penetration through the tumour capsule Patterns of Capsular Pseudoinvasion (CPI)
4 WHAFFT Worrisome histologic alterations following FNA of the thyroid. LiVolsi VA, Merino MJ. Lab Invest 62, VASCULAR (VI) Hemorrhage and hemosiderin Focal and geographic pattern of lesion Patterns of Vascular Invasion (VI) Patterns of Vascular Invasion (VI) Artifactuallydislodged tumour cell (or tissue) Pseudo VI Capsular invasion is defined by the presence of intravascular tumourcells either covered by endothelium or associated with thrombus. (WHO 2004) Capsular invasion is defined by the presence of intravascular tumourcells either covered by endothelium or associated with thrombus. (WHO 2004) Patterns of Pseudovascular Invasion (VI) DIAGNOSIS OF FOLLICULAR CARCINOMA Pseudo VI Follicular tumours Artifactually dislodged tumour cells (or tissue) showing definite invasion showing questionable invasion PTC nuclei (-) Follicular tumors of uncertain malignant potential (FT-UMP) PTC nuclei (questionable) Well differentiated tumour of uncertain malignant potential (WDT-UMP) Williams ED Int J Surg Pathol 2000, 8:
5 IMMUNOHISTOCHEMICAL DEMONSTRATION OF LYMPHATIC AND BLOOD VESSELS IMMUNOHISTOCHEMISTRY Vascular Markers Factor VIII Laminin CD31 or CD34 Type IV collagen Ulex europaeus lectin Elastic tissue stains : only limited use in identifying intracapsular vessels CD34 CD34 FLT4 IMMUNOHISTOCHEMISTRY Lymphatic Markers Live-1 D2-40 DISTRIBUTION OF LYMPHATIC AND BLOOD VESSELS IN THE FOLLICULAR THYROID TUMOURS D2-40 Lymphaic and blood vessel density in the follicular patterned lesions of thyroid DISTRIBUTION OF LYMPHATIC VESSELS IN ENCAPSULATED FOLLICULAR TUMORS Intratumoral region Follicular variant Of PTC Follicular adenoma Intratumoral lymphatic vessel density D2-40 staining Lymphatic vessels Peritumoral region Intratumoral lymphatic vessel density was significantly higher in the follicular variant of PTC than in either follicular adenoma or follicular carcinoma. Giogrgadeze TA, et al. Mod Pathol (2005) 18: Normal Intracapsular lymphatic vessels: scant or none
6 DISTRIBUTION OF BLOOD VESSELS IN ENCAPSULATED FOLLICULAR TUMORS DISTRIBUTION OF LYMPHATIC AND BLOOD VESSELS CD34 staining Blood vessels CD34 staining for blood vessels ( ) + D2-40 staining for lymphatic vessels ( ) Capillaries Minimally invasive follicular carcinoma (Encapsulated follicular carcinoma) with vascular and capsular invasions Intratumoral vessels Intrapsular vessels Peritumoral vessels s tend to give rise to hematogenous spread and do not usually show lymphatic spread possibly due to lymphatic and blood vessel distributions. THICKNESS OF TUMOR CAPSULE CAPSULE THICKNESS Follicular adenomas (20 s) Minimally invasive follicular thyroid carcinomas (48 s) thickness The capsule of follicular carcinoma tends to be thicker and more irregular than that of adenoma. Evans, H.L. Cancer 54: , 1984 Yamashina M. Am J Surg Pathol 1992, 16: Follicular adenoma thickness (µm) mean 174 SD The follicular carcinoma tends to be surrounded by a wide thick capsule. SUBTYPES OF FTC AND RECURRENCE AND/OR METASTASIS NO. OF VASCULAR IN SUBTYPES OF FTC Without recurrence and/or distant With recurrence and/or distant No. vascular invasion More than 4 25% % 0 31% No. vascular invasion More than 4 79% Widely invasive FTC Inc. poorly Widely invasive FTC (INC. POORLY) s with recurrence and/or distant vascular invasion Widely invasive FTC (23%) 11 (79%) Widely invasive FTC : capsular invasion alone
7 NO. OF VASCULAR AND RECURRENCE AND/OR METASTASIS IN MINIMALLY INVASIVE FTC SIGNIFICANCE OF vascular invasion (VI) VI< 4 VI>= 4 64% With recurrence and/or Without 19% Encapsulated Widely invasive With capsular invasion only With limited (<4) vascular invasion With extensive (>=4) vascular invasion Rosai J. Surgical Pathology, 9 th ed vascular invasion 0 1 2, Without With There is a prognostic difference depending on the number of vessels involved. STI PATTERN IN MINIMALLY INVASIVE FTC DISTANT METASTASIS IN MINIMALLY INVASIVE FTC size Gender Not significant for thickness The capsule of MI-FTC is thicker than that of adenoma STI Absent Present Solid Trabecular Insular 18% 33% STI pattern With Absent 33 6 (18%) With Capsular invasion Not significant for Vascular invasion Number of VI could be important With extensive (>=4) vascular invasion Solid, Trabecular, and Insular patterns Possible significant marker Present 15 5 (33%)
<1 cm WDT-UMP, FT-UMP. Kakudo K et al, Pathol Int,2009, Endocr J, 2011 and Pathol Int, 2012
More information
ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA
Papillary carcinoma is the most common of thyroid malignancies and occurs in all age groups but particularly in women under 45 years of age. There is a high rate of cervical metastatic disease and yet
More informationThe Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.
Where does Molecular Analysis of FNA Specimens fit into the evaluation of thyroid nodules? The Role of Genetic Testing in the Evaluation of Thyroid Nodules Ultrasound TSH Risk factors Jill E. Langer, MD
More informationClassificazioni citologiche: verso uno schema internazionale unificato?
Cytology and molecular biology for thyroid nodules diagnos6c categories to clinical ac6ons From Classificazioni citologiche: verso uno schema internazionale unificato? A. Crescenzi Diagnostic categories
More informationSUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD Case Presentation 35 year old male referred from PMD with an asymptomatic palpable right neck mass PMH/PSH:
More informationOBJECTIVES By the end of this segment, the community participant will be able to:
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
More informationOutline. Workup for metastatic breast cancer. Metastatic breast cancer
Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30
More informationGENETICS AND GENOMICS OF THYROID NEOPLASMS MOVING CLOSER TOWARDS PERSONALIZED PATIENT CARE
Genomics in Medicine Series GENETICS AND GENOMICS OF THYROID NEOPLASMS MOVING CLOSER TOWARDS PERSONALIZED PATIENT CARE Electron Kebebew, MD, FACS Outline To assess the change in thyroid cancer epidemiology
More informationTHYROID CANCER. I. Introduction
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
More informationIl percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare
Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare Maria Chiara Zatelli Sezione di Endocrinologia Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università
More informationCorporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid
Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_markers_in_fine_needle_aspirates_of_the_thyroid
More informationAdvances in Differentiated Thyroid Cancer
Advances in Differentiated Thyroid Cancer Steven A. De Jong, M.D., FACS, FACE Professor and Vice Chair Clinical Affairs Department of Surgery Loyola University Medical Center Thyroid Cancer classification
More informationThyroid and Adrenal Gland
Thyroid and Adrenal Gland NAACCR 2011 2012 Webinar Series 12/1/11 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationValidation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach
Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach Kerry C. Councilman, MD Assistant Professor University of Colorado Denver Goals: BRAF Mutation
More information9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH
9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH Differentiated thyroid cancer expresses the TSH receptor on the cell membrane and responds to TSH stimulation by increasing
More informationRenal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD
Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD Department of Pathology University of Szeged, Hungary ISUP Vancouver Classification of Renal Neoplasia Am J Surg Pathol 37:14691489, 2013 13 histologic
More informationSurgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科
Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科 Papillary microcarcinoma of thyroid Definition latent aberrant thyroid occult thyroid carcinoma latent papillary carcinoma)
More informationThyroid Cancer Diagnosis and Management. Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010
Thyroid Cancer Diagnosis and Management Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010 DISCLOSURE NOTHING TO DISCLOSE in regard to financial conflict
More informationUpdate on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
More information330 Diagnostic Cytopathology, Vol 34, No 5 # 2006 WILEY-LISS, INC.
Does Hurthle Cell Lesion/Neoplasm Predict Malignancy More Than Follicular Lesion/Neoplasm on Thyroid Fine-Needle Aspiration? Robert T. Pu, M.D., Ph.D., 1 * Jack Yang, M.D., 2 Patricia G. Wasserman, M.D.,
More informationLung Carcinomas New 2015 WHO Classification. Spasenija Savic Pathology
Lung Carcinomas New 2015 WHO Classification Spasenija Savic Pathology ***EXPECTED SPRING 2015*** This authoritative, concise reference book provides an international standard for oncologists and pathologists
More informationHow to report Upper GI EMR/ESD specimens
Section of Pathology and Tumour Biology How to report Upper GI EMR/ESD specimens Dr.H.Grabsch Warning. Most of the criteria, methodologies, evidence presented in this talk are based on studies in early
More informationBRAF as a prognostic marker in papillary thyroid cancer
12 Congresso Nazionale AME Molecular markers in thyroid cancer: current role in clinical practice BRAF as a prognostic marker in papillary thyroid cancer Dott. ssa Cristina Romei Sezione di Endocrinologia
More informationMolecular Diagnostics in Thyroid Cancer
Disclosure Nothing to disclose Jonathan George, MD, MPH Assistant Professor Head and Neck Oncologic & Endocrine Surgery Molecular Diagnostics in Thyroid Cancer Current Practices & Future Trends UCSF Medical
More informationThyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules)
Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules) Jeffrey S. Freeman, D.O., F.A.C.O.I. Chairman, Division of Endocrinology and Metabolism Philadelphia College
More informationConflict of Interest. Overdiagnosis. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates 4/17/2015. Jeffrey F.
Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates Jeffrey F. Krane, MD PhD Associate Professor of Pathology Harvard Medical School Chief, Head and Neck Pathology Service Associate Director,
More informationMEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15
MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases,
More informationBRAF in the diagnostic evaluation of thyroid nodules
Symposium 13 Molecular markers in thyroid cancer: current role in clinical practice BRAF in the diagnostic evaluation of thyroid nodules Laura Fugazzola University of Milan, Italy Papillary carcinoma BRAF
More informationCytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium
Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Introduction 3 cavities with the same embryologic origin the mesoderme Pleura Exudates Pleura Peritoneum Pericardium 22%
More informationInformation Model Requirements of Post-Coordinated SNOMED CT Expressions for Structured Pathology Reports
Information Model Requirements of Post-Coordinated SNOMED CT Expressions for Structured Pathology Reports W. Scott Campbell, Ph.D., MBA James R. Campbell, MD Acknowledgements Steven H. Hinrichs, MD Chairman
More informationMALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,
More informationMALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied
More informationPRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT
PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT Dott. Francesco Pontieri (*) U.O. di Anatomia Patologica P.O. di Rossano (CS) Dott. Gian Franco Zannoni Anatomia Patologica Facoltà di Medicina e Chirurgia
More informationMolecular Pathogenesis of Thyroid Cancer
Introduction Thyroid cancer is the fastest growing cancer diagnosis in the US [1, 2] with a total of 44,670 new cases and 1,690 deaths expected in 2010 (www.cancer.gov/cancertopics/types/thyroid). From
More informationDiagnosis of Mesothelioma Pitfalls and Practical Information
Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com
More informationSomething Old, Something New.
Something Old, Something New. Michelle A. Fajardo, D.O. Loma Linda University Medical Center Clinical Presentation 6 year old boy, presented with hematuria Renal mass demonstrated by ultrasound & CT scan
More informationReview Article Encapsulated papillary thyroid carcinoma, follicular variant: A misnomerpin_2773 155..160
Pathology International 2012; 62: 155 160 doi:10.1111/j.1440-1827.2011.02773.x Review Article Encapsulated papillary thyroid carcinoma, follicular variant: A misnomerpin_2773 155..160 Kennichi Kakudo,
More informationMorphological Variants of Papillary Carcinoma of Thyroid
Morphological Variants of Papillary Carcinoma of Thyroid *Alam MA, 1 Islam KN, 2 Ali SM, 3 Rahman AN, 4 Kamal M 5 An observational study was carried out at the Department of Pathology, BSMMU to see the
More informationSEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS
SEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS LEARNING OBJECTIVES At the end of the lecture, students should be able to: Know the pathology of renal tumors. RENAL TUMORS RENAL PAPILLARY ADENOMA Common
More informationKidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
More informationEpithelial Tumors of the Kidney Diagnostic Problems and Recently Described Entities
Pathology of Renal Neoplasia Epithelial Tumors of the Kidney Diagnostic Problems and Recently Described Entities Wael A Sakr, MD Wayne State University School of Medicine CURRENT CLASSIFICATION = EPITHELIAL
More informationYOUR LUNG CANCER PATHOLOGY REPORT
UNDERSTANDING YOUR LUNG CANCER PATHOLOGY REPORT 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 CONTENTS What is a Pathology Report?...3 The Basics...4 Sections of a Pathology Report...7
More informationMolecular Markers in Fine Needle Aspirates of the Thyroid
Molecular Markers in Fine Needle Aspirates of the Thyroid Policy Number: 2.04.78 Last Review: 3/2015 Origination: 3/2013 Next Review: 3/2016 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will
More informationFrozen Section Diagnosis
Frozen Section Diagnosis Dr Catherine M Corbishley Honorary Consultant Histopathologist St George s Healthcare NHS Trust and lead examiner final FRCPath Practical 2008-2011 Frozen Section Diagnosis The
More informationThe develpemental origin of mesothelium
Mesothelioma Tallinn 14.12.06 Henrik Wolff Finnish Institute of Occupational Health The develpemental origin of mesothelium Mesodermal cavities (pleura, peritoneum and pericardium ) are lined with mesenchymal
More informationChanges in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred
More informationName of Policy: Molecular Markers in Fine Needle Aspirates of the Thyroid
Name of Policy: Molecular Markers in Fine Needle Aspirates of the Thyroid Policy #: 516 Latest Review Date: June 2015 Category: Laboratory Policy Grade: B Background/Definitions: As a general rule, benefits
More informationPATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet
PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry M. Praet Pathology of the Pleura Normal serosa: visceral and parietal layers Inflammation Neoplasia: Primary: mesothelioma
More informationBreast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.
Breast Cancer: from bedside and grossing room to diagnoses and beyond Adriana Corben, M.D. About breast anatomy Breasts are special organs that develop in women during puberty when female hormones are
More informationLYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons
LYMPHOMA BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons Normal development of lymphocytes Lymphocyte proliferation and differentiation:
More informationBreast Ultrasound: Benign vs. Malignant Lesions
October 25-November 19, 2004 Breast Ultrasound: Benign vs. Malignant Lesions Jill Steinkeler,, Tufts University School of Medicine IV Breast Anatomy Case Presentation-Patient 1 62 year old woman with a
More informationRenal Tumors with Eosinophilic Cytoplasm: 2013 Classification. Jesse K. McKenney, MD Associate Head, Surgical Pathology
Renal Tumors with Eosinophilic Cytoplasm: 2013 Classification Jesse K. McKenney, MD Associate Head, Surgical Pathology Renal Epithelial Neoplasia History 1981: WHO Classification of Renal Neoplasms 1.
More informationRENAL CELL CARCINOMA EPIDEMIOLOGY
RENAL CELL CARCINOMA: THE 2012 ISUP VANCOUVER CLASSIFICATION David Grignon MD, Indiana University, Indianapolis, IN RENAL CELL CARCINOMA EPIDEMIOLOGY Siegel et al. CaA Cancer J Clin 63:11-30, 2013 1 EPITHELIAL
More informationKIDNEY CARCINOMA ASSOCIATED WITH XP11.2 TRANSLOCATION / TFE3 (ASPL-TFE3) GENE FUSION
Case Report International Braz J Urol Official Journal of the Brazilian Society of Urology KIDNEY CA AND Xp11.2 TRANSLOCATION Vol. 31 (3): 251-255, May - June, 2005 KIDNEY CARCINOMA ASSOCIATED WITH XP11.2
More informationSurgical Perspective of T1799A BRAF Mutation Diagnostic Value in Papillary Thyroid Carcinoma
DOI:http://dx.doi.org/10.7314/APJCP.2013.14.1.31 RESEARCH ARTICLE Surgical Perspective of T1799A BRAF Mutation Diagnostic Value in Papillary Thyroid Carcinoma Bayu Brahma 1 *, Erwin Danil Yulian 2, Muchlis
More informationThe Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
More informationThyroid Cancer: Resection, Dissection, Surveillance and Recurrence. Cord Sturgeon, MD
Thyroid Cancer: Resection, Dissection, Surveillance and Recurrence Cord Sturgeon, MD Associate Professor of Surgery Northwestern University Feinberg School of Medicine Director of Endocrine Surgery Chicago,
More informationApplication of Molecular Diagnosis: Present and Future
Application of Molecular Diagnosis: Present and Future Dong Jun Lim, MD., PhD. Associate Professor Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary s Hospital,
More informationMedical Policy Manual. Topic: Molecular Markers in Fine Needle Aspirates of the Thyroid. Date of Origin: April 2013
Medical Policy Manual Topic: Molecular Markers in Fine Needle Aspirates of the Thyroid Date of Origin: April 2013 Section: Genetic Testing Last Reviewed Date: December 2015 Policy No: 49 Effective Date:
More informationTUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD
TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD Victor E. Reuter, MD Memorial Sloan-Kettering Cancer Center reuterv@mskcc.org 66 th Annual Pathology Seminar California Society of Pathologists Short
More informationPathology of lung cancer
Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu
More informationCASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY
CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE HISTORY 52Y MALE RIGHT RADICAL NEPHERECTOMY Case of right renal mass with IVC thrombus. History of surgery and RT for right occipital
More informationMAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER
Renal tumours WHO 4 MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER Molecular differential pathology of renal cell tumours G. KOVACS A CLASSIFICATION BASED ON UNDERSTANDING THE GENETIC
More informationDiagnostic Challenge. Department of Pathology,
Cytology of Pleural Fluid as a Diagnostic Challenge Paavo Pääkkö,, MD, PhD Chief Physician and Head of the Department Department of Pathology, Oulu University Hospital,, Finland Oulu University Hospital
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): 4/1/2015 Most Recent Review Date (Revised): 11/24/2015 Effective Date: 2/1/2016 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS
More informationIntroduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.
Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic
More informationThe evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS
The evolving pathology of solitary fibrous tumours Luciane Dreher Irion MREH / CMFT / NSOPS Historical review Haemangiopericytoma (HPC) first described primarily as a soft tissue vascular tumour of pericytic
More informationToday s Topics. Tumors of the Peritoneum in Women
Today s Topics Tumors of the Peritoneum in Women Charles Zaloudek, M.D. Department of Pathology 505 Parnassus Ave., M563 University of California, San Francisco San Francisco, CA USA charles.zaloudek@ucsf.edu
More informationOverview 1/28/2013. Bethesda System Cytology Categories and Molecular Alterations in Thyroid FNA Specimens
Bethesda System Cytology Categories and Molecular Alterations in Thyroid FNA Specimens N. Paul Ohori, M.D. Department of Pathology University of Pittsburgh Medical Center Pittsburgh, Pennsylvania N. Paul
More informationYour Guide to the Breast Cancer Pathology Report
Your Guide to the Breast Cancer Pathology Report Developed for you by Breastcancer.org is a nonprofit organization dedicated to providing education and information on breast health and breast cancer. The
More informationThyroid FNA Ancillary Studies. Douglas P. Clark, M.D. Zubair W. Baloch, M.D., Ph.D.
Thyroid FNA Ancillary Studies Douglas P. Clark, M.D. Zubair W. Baloch, M.D., Ph.D. What are the goals of ancillary studies of thyroid FNAs? Characterization of a known malignancy (
More informationWriting Group for the AACE Thyroid Scientific Committee. Bernet V, Hupart KH, Parangi S and Woeber KA
Molecular Diagnostic Testing of Thyroid Nodules with Indeterminate Cytopathology Summary Highlights Writing Group for the AACE Thyroid Scientific Committee Bernet V, Hupart KH, Parangi S and Woeber KA
More informationMalignant Lymphomas and Plasma Cell Myeloma
Malignant Lymphomas and Plasma Cell Myeloma Dr. Bruce F. Burns Dept. of Pathology and Lab Medicine Overview definitions - lymphoma lymphoproliferative disorder plasma cell myeloma pathogenesis - translocations
More informationA912: Kidney, Renal cell carcinoma
A912: Kidney, Renal cell carcinoma General facts of kidney cancer Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type
More informationA 70-year old Man with Pleural Effusion
Mesothelioma Diagnosis: Pitfalls and Latest Updates S Klebe and DW Henderson Recommendations Indisputable malignant cells on cytomorphological criteria which demonstrate a mesothelial phenotype, which
More informationThe Relationship Between Lymphocytic Infiltration in the Thyroid Gland and Tumor Recurrence in Papillary Thyroid Carcinoma
Turkish Journal of Endocrinology and Metabolism, (1999) 3 : 113-117 ORIGINAL ARTICLE The Relationship Between Lymphocytic Infiltration in the Thyroid Gland and Tumor Recurrence in Papillary Thyroid Carcinoma
More informationAtypical uterine leiomyoma: a case report and review of the literature
Manxhuka-Kerliu et al. Journal of Medical Case Reports (2016) 10:22 DOI 10.1186/s13256-016-0800-3 CASE REPORT Open Access Atypical uterine leiomyoma: a case report and review of the literature Suzana Manxhuka-Kerliu
More informationPractical Effusion Cytology
Practical Effusion Cytology A Community Pathologist s Approach to Immunocytochemistry in Body Fluid Cytology Emily E. Volk, MD William Beaumont Hospital Troy, MI College of American Pathologists 2004.
More informationFalse positive PET in lymphoma
False positive PET in lymphoma Thomas Krause Introduction and conclusion 2 3 Introduction 4 FDG-PET in staging of lymphoma 34 studies with 2227 Patients CT FDG-PET Sensitivity 63 % 89 % (58%-100%) (63%-100%)
More informationYour Guide to Express Critical Illness Insurance Definitions
Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses
More informationHepatocellular Carcinoma: What the hepatologist wants to know
Hepatocellular Carcinoma: What the hepatologist wants to know Hélène Castel, MD Liver Unit Hôpital St-Luc CHUM? CAR Annual Scientific Meeting Saturday, April 27 th 2013 Disclosure statement I do not have
More informationWORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14 BEFORE: M. Crystal: Vice-Chair HEARING: August 20, 2014 at Toronto Written DATE OF DECISION: December 4, 2014 NEUTRAL CITATION: 2014
More informationThyroid Cancer. What is thyroid cancer? The thyroid gland
Thyroid Cancer What is thyroid cancer? Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer, and can spread to other areas of the body.
More informationINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing
More informationMETASTATIC CLEAR CELL RENAL CELL CARCINOMA TO THE SUBCUTANEOUS AREA IN ILLIAC FOSSA AND ADRENAL GLAND WITHOUT AN IDENTIFIABLE PRIMARY TUMOR
Indian J.Sci.Res. 5(1) : 121-125, 2014 METASTATIC CLEAR CELL RENAL CELL CARCINOMA TO THE SUBCUTANEOUS AREA IN ILLIAC FOSSA AND ADRENAL GLAND WITHOUT AN IDENTIFIABLE PRIMARY TUMOR a1 b c d REETA DHAR, SHILPI
More informationImmunohistochemical differentiation of metastatic tumours
Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in
More informationPROTOCOL OF THE RITA DATA QUALITY STUDY
PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of
More informationUnderstanding Metastatic Disease
Supported by an unrestricted educational grant from Pfizer Understanding Metastatic Disease Metastatic disease or metastases are phrases that mean the same as Secondary cancer. This means that the cancer
More informationPediatric Oncology for Otolaryngologists
Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department
More informationGuideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer
Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer Version History Version Date Summary of Change/Process 0.1 09.01.11
More informationWell-differentiated Thyroid Carcinoma: Factors Predicting Recurrence and Survival
Singapore Med J 2002 Vol 43(9) : 457-462 O r i g i n a l A r t i c l e Well-differentiated Thyroid Carcinoma: Factors Predicting Recurrence and Survival L H Y Lim, K C Soo, Y K Chong, F Gao, G S Hong,
More informationKevin H. Hsu, MS, DO, Corrado Minimo MD, Seth Zwillenberg, MD
A Patient with Synchronous Follicular (Hurthle Cell), Papillary, and Medullary Thyroid Carcinomas: A Case Report with Literature Review on Possible Incidence and Pathogenesis Kevin H. Hsu, MS, DO, Corrado
More informationWisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics
Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics In Situ Breast Cancer in Wisconsin INTRODUCTION This bulletin provides information
More informationNotice of Faculty Disclosure
The Diagnosis of Malignant Mesothelioma Andrew Churg, MD Department of Pathology University of British Columbia Vancouver, BC, Canada achurg@mail.ubc.ca Notice of Faculty Disclosure In accordance with
More informationMammography Education, Inc.
Mammography Education, Inc. 2011 LÁSZLÓ TABÁR, M.D.,F.A.C.R (Hon) 3D image of a milk duct MULTIMODALITY DETECTION and DIAGNOSIS of BREAST DISEASES PRAGUE, Czech Republic Crown Plaza, Prague June 29 - July
More informationAACE Advances in Medical and Surgical Management of Thyroid Cancer, 2015. Tampa, Florida.
AACE Advances in Medical and Surgical Management of Thyroid Cancer, 2015. Tampa, Florida. Dev Abraham MD, MRCP (UK), ECNU Professor of Medicine, Division of Endocrinology, Huntsman Cancer Institute, University
More informationGladwyn Leiman, MCCCh, FIAC, FRCPath Scott Anderson, MD
Cytology Works shop #5 Gladwyn Leiman, MCCCh, FIAC, FRCPath Scott Anderson, MD Disclosur re information The speakers have no relationship that represents a possible conflict of interest with respect to
More informationAcadémie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas
Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger Immunohistochemistry in malignant mesotheliomas Françoise Thivolet-Béjui Groupement Hospitalier Est Lyon-Bron
More informationManagement of Well Differentiated Thyroid Cancers: Where We Have Been and Where We are Headed
Management of Well Differentiated Thyroid Cancers: Where We Have Been and Where We are Headed Medical Grand Rounds December 10,2015 Christine Signore, MD ECNU Learning Objectives Discuss the epidemiology
More information